OVARIAN NEOPLASMS
Clinical trials for OVARIAN NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new OVARIAN NEOPLASMS trials appear
Sign up with your email to follow new studies for OVARIAN NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested as potential lifeline for Tough-to-Treat cancers
Disease control TerminatedThis early-stage study tested a new oral drug called NKT3447 in adults with advanced solid tumors that had progressed despite standard treatments. The main goals were to find a safe dose and see how the body processes the drug. The study was later terminated and focused on specif…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Early cancer drug trial halted after safety testing
Disease control TerminatedThis early-stage study aimed to test the safety and find the right dose of a new drug called Felmetatug Vedotin for people with advanced solid tumors. It was for adults with cancers like ovarian, breast, lung, and others that had spread or could not be removed by surgery. The tri…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
Targeted drug tested against chemo for shrinking ovarian tumors before surgery
Disease control TerminatedThis study aimed to see if a targeted drug called niraparib works better than standard chemotherapy to shrink tumors before surgery in people with advanced ovarian cancer that has specific genetic features. It involved 36 participants with newly diagnosed stage III or IV ovarian …
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE2 • Sponsor: Tesaro, Inc. • Aim: Disease control
Last updated Mar 10, 2026 12:52 UTC